17.10.2023 • News

Thierry Van Nieuwenhove Appointed as CEO of Quotient Sciences

UK-headquartered drug development and manufacturing organization (CDMO) Quotient Sciences has appointed Thierry Van Nieuwenhove as its new CEO, effective Oct. 16, 2023. He succeeds Mark Egerton who retires after 18 years in this role.

As part of the leadership transition, the company also appointed Wayne Hewett as non-executive chairman.

Van Nieuwenhove, who has over 23 years of professional experience in the pharma/CDMO industry, joins Quotient from ABL where he was CEO for the last two years. Prior to this, he held various leadership roles in the CDMO industry, including Novasep, Lonza, and Minakem.

Hewett has more than three decades of board and leadership experience. He is currently chairman of CDMO Cambrex and serves on the board of directors of The Home Depot, Wells Fargo, UPS and Lytx, as well as a senior adviser to Permira.

Company

Quotient Sciences

Mere Way, Ruddington
NG11 6JS Nottingham
UK

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.